The International Multicohort Consortium of Infectious Disease study group
AIDS Therapy Evaluation in the Netherlands Cohort (ATHENA): F Wit, P Reiss, M Hillebregt, Stichting HIV Monitoring (SHM), Amsterdam, Netherlands
The Australian HIV Observational Database (AHOD): M Law, K Petoumenos, N Rose, J Hutchinson, UNSW Sydney, Sydney, Australia
Austrian HIV Cohort Study (AHIVCOS): R Zangerle, H Appoyer, Medizinische Universität Innsbruck, Innsbruch, Austria
CHU Saint-Pierre, S De Wit, M Delforge, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium
EuroSIDA Cohort: Gilles Wandeler, CHIP, Rigshospitalet, RegionH, Copenhagen, Denmark
Frankfurt HIV Cohort Study: C Stephan, M Bucht, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany
Georgian National AIDS Health Information System (AIDS HIS): N Chkhartishvili, O Chokoshvili, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
Italian Cohort Naive Antiretrovirals (ICONA): A d’Arminio Monforte, A Rodano, A Tavelli, ASST Santi Paolo e Carlo, Milan, Italy; I Fanti, Icona Foundation, Milan, Italy.
Modena HIV Cohort: C Mussini, V Borghi, Università degli Studi di Modena, Modena, Italy
Nice HIV Cohort: C Pradier, E Fontas, K Dollet, C Caissotti, Université Côte d’Azur et Centre Hospitalier Universitaire, Nice, France.
PISCIS Cohort Study: J Casabona, JM Miro, Centre Estudis Epidemiologics de ITS i VIH de Catalunya (CEEISCAT), Badalona, Spain
Royal Free Hospital Cohort: C Smith, F Lampe, M Johnson, F Burns, C Chaloner, Royal Free Hospital, University College London, London, United Kingdom
San Raffaele Scientific Institute: A Castagna, A Lazzarin, A Poli, Università Vita-Salute San Raffaele, Milano, Italy
Swedish InfCare HIV Cohort: A Sönnerborg, K Falconer, V Svedhem, Karolinska University Hospital, Stockholm, Sweden
Swiss HIV Cohort Study (SHCS): H Günthard, B Ledergerber, H Bucher, A Scherrer, University of Zurich, Zurich, Switzerland
University Hospital Bonn: JC Wasmuth, J Rockstroh, Bonn, Germany
University Hospital Cologne: JJ Vehreschild, G. Fätkenheuer, M Stecher, N Schulze, B Franke, Cologne, Germany
RESPOND Executive Committee
A Mocroft*, J Rooney, I McNicholl, V Vannappagari, H Garges, G Wandeler, M Law, R Zangerle, C Smith, S De Wit, J Lundgren, H Günthard
*Chair
RESPOND Scientific Steering Committee
J Lundgren*, H Günthard*, J Kowalska, D Raben, L Ryom, A Mocroft, J Rockstroh, L Peters, A Volny Anne, N Dedes, ED Williams, N Chkhartishvili, R Zangerle, M Law, F Wit, C Necsoi, G Wandeler, C Stephan, C Pradier, A D’Arminio Monforte, C Mussini, A Bruguera, H Bucher, A Sönnerborg, JJ Vehreschild, JC Wasmuth, C Smith, A Castagna, J Rooney, I McNicholl, V Vannappagari, H Garges
*Chairs
Community Representatives:
Alain Volny-Anne, Nikos Dedes, Luis Mendao (European AIDS Treatment Group), Esther Dixon Williams (UK)
RESPOND Staff
Coordinating Centre Staff: JF Larsen, B Neesgaard, D Raben, L Ryom, L Peters, ML Jakobsen, T Bruun, A Bojesen
Data Management Staff: EV Hansen, AK Traytel, TW Elsing, D Kristensen, S Thomsen, T Weide
Statistical Staff: A Mocroft, L Greenberg, L Bansi-Matharu, A Pelchen-Matthews, K Petoumenos, N Rose, D. Byonanebye
Funding
The International Cohort Consortium of Infectious Disease (RESPOND) has received funding from ViiV Healthcare LLC and Gilead Sciences. Additional support has been provided by participating cohorts contributing data in-kind and/or statistical support: Austrian HIV Cohort Study (AHIVCOS), The Australian HIV Observational Database (AHOD), CHU Saint-Pierre, University Hospital Cologne, EuroSIDA, Frankfurt HIV Cohort Study, Georgian National AIDS Health Information System (AIDS HIS), Modena HIV Cohort, San Raffaele Scientific Institute, Swiss HIV Cohort Study (SHCS), AIDS Therapy Evaluation in the Netherlands Cohort (ATHENA), Royal Free HIV Cohort Study.